Scholars Central

Conference abstractPublished 23 Jun 2023

Biosimilars interchangeability: The draft guidance in the USA

Authors: Michel Mikhail

International Expert in Biosimilars, Germany

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In the USA only interchangeable products can be substituted for the reference product by a pharmacist without the intervention of a health care provider. The interchangeability regulation is in the form of guidance: Interchangeable biologics must be biosimilar to the reference biologic. If administered more than once, data must show the safety and efficacy risks of switching. If not administered more than once, justify the omission of a switching study. The clinical data must demonstrate switching risk in all of the reference biologic’s licensed conditions of use. The data must support the “totality of the evidence” and “reduction of residual uncertainty”. Switching study design is defined and described in the guidance. Guidance describes what is insufficient to demonstrate interchangeability. The use of post-marketing data from a biosimilar. The presentation and design attributes must be the same to enable substitution. The impact of biosimilar interchangeability in the USA will be more than positive. Where will an interchangeable biosimilar have the most impact? An interchangeability rating may result in the perception that the product is superior in quality to other biosimilars. How will payors react? Likely competitor response.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Biomedical and Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Biomedical and Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Michel Mikhail”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels